191 related articles for article (PubMed ID: 29242151)
41. Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells.
Tang FY; Chiang EP; Sun YC
J Nutr Biochem; 2008 May; 19(5):287-94. PubMed ID: 17651959
[TBL] [Abstract][Full Text] [Related]
42. Antiproliferative effect of resveratrol in human prostate carcinoma cells.
Kim YA; Rhee SH; Park KY; Choi YH
J Med Food; 2003; 6(4):273-80. PubMed ID: 14977434
[TBL] [Abstract][Full Text] [Related]
43. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
44. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
45. Identification of a p53-dependent pathway in the induction of apoptosis of human breast cancer cells by the natural product, resveratrol.
Laux MT; Aregullin M; Berry JP; Flanders JA; Rodriguez E
J Altern Complement Med; 2004 Apr; 10(2):235-9. PubMed ID: 15165403
[TBL] [Abstract][Full Text] [Related]
46. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
47. Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.
Ashikari D; Takayama K; Tanaka T; Suzuki Y; Obinata D; Fujimura T; Urano T; Takahashi S; Inoue S
Oncogene; 2017 Nov; 36(45):6272-6281. PubMed ID: 28692047
[TBL] [Abstract][Full Text] [Related]
48. Over-expression of small ubiquitin-related modifier-1 and sumoylated p53 in colon cancer.
Zhang H; Kuai X; Ji Z; Li Z; Shi R
Cell Biochem Biophys; 2013; 67(3):1081-7. PubMed ID: 23640307
[TBL] [Abstract][Full Text] [Related]
49. Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines.
Amiri F; Zarnani AH; Zand H; Koohdani F; Jeddi-Tehrani M; Vafa M
Eur J Pharmacol; 2013 Oct; 718(1-3):34-40. PubMed ID: 24055188
[TBL] [Abstract][Full Text] [Related]
50. Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: Novel cellular mechanisms involving the ERKs/p53 cascade.
Alkhalaf M; Jaffal S
Free Radic Biol Med; 2006 Jul; 41(2):318-25. PubMed ID: 16814113
[TBL] [Abstract][Full Text] [Related]
51. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells.
Liao PC; Ng LT; Lin LT; Richardson CD; Wang GH; Lin CC
J Med Food; 2010 Dec; 13(6):1415-23. PubMed ID: 20946021
[TBL] [Abstract][Full Text] [Related]
52. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
Liontas A; Yeger H
Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
[TBL] [Abstract][Full Text] [Related]
53. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
54. Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells.
Ferraz da Costa DC; Casanova FA; Quarti J; Malheiros MS; Sanches D; Dos Santos PS; Fialho E; Silva JL
PLoS One; 2012; 7(11):e48746. PubMed ID: 23152798
[TBL] [Abstract][Full Text] [Related]
55. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
[TBL] [Abstract][Full Text] [Related]
56. SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells.
Horndasch M; Culig Z
Prostate; 2011 Sep; 71(12):1357-66. PubMed ID: 21308719
[TBL] [Abstract][Full Text] [Related]
57. Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer.
Zhu C; Zhu Q; Wu Z; Yin Y; Kang D; Lu S; Liu P
J Cell Physiol; 2018 Feb; 233(2):1104-1119. PubMed ID: 28422286
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling.
Rasheduzzaman M; Jeong JK; Park SY
Life Sci; 2018 Sep; 208():208-220. PubMed ID: 30031063
[TBL] [Abstract][Full Text] [Related]
59. SUMO-1 Promotes Ishikawa Cell Proliferation and Apoptosis in Endometrial Cancer by Increasing Sumoylation of Histone H4.
Zheng J; Liu L; Wang S; Huang X
Int J Gynecol Cancer; 2015 Oct; 25(8):1364-8. PubMed ID: 26222483
[TBL] [Abstract][Full Text] [Related]
60. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
